Navigation Links
Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials

BRANFORD, Conn.--(BUSINESS WIRE)--Jun 25, 2007 - Neurogen Corporation (Nasdaq: NRGN) today announced positive top-line results from two dose-ranging, Phase 2b clinical trials in chronic insomnia patients with the Company's proprietary insomnia agent, NG2-73, an alpha-3 preferring GABA(A) partial agonist. Multiple formulations were studied in each trial to determine the best profile for rapidity of sleep onset and maintenance of sleep through the night without residual sedation the next day.

The objective of the first trial--Study 202--was to measure efficacy in sleep maintenance, or the ability to maintain sleep throughout the night after falling asleep. In this study, NG2-73 achieved statistically significant results versus placebo (overall p less than 0.001) at all doses tested in the primary endpoint of sleep maintenance (measured by Wake After Sleep Onset - or WASO). Study 202 was the first study in which NG2-73 has been studied for sleep maintenance in chronic insomnia patients and confirms efficacy in this group. It included eight different controlled release doses of the compound.

The objective of the second trial - Study 203 - was to demonstrate efficacy in sleep onset, or the amount of time it takes to fall asleep, in chronic insomnia patients. In this study, NG2-73 achieved statistically significant results versus placebo (overall p less than 0.0001) at all doses tested in the primary endpoint of sleep onset (measured by Latency to Persistent Sleep - or LPS on the first two nights of treatment). Study 203 included two immediate release forms and three controlled release doses of NG2-73.

William H. Koster, PhD, President and CEO of Neurogen, said, "We are very pleased with the results of these studies. We wanted to answer two questions in these trials. First, can we achieve our target profile in chronic insomnia patients of rapid onset of sleep which is maintained throughout the night wit
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
2. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
3. Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:6/19/2013)... SANTA CLARA, Calif. , June 19, 2013 ... and control solutions for life sciences process applications, ... 3L glass bioreactors for upstream cell culture and ... in a new product family of Finesse bioreactors ... R&D and cGMP applications.  They are fully compatible ...
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
(Date:6/19/2013)... 19, 2013 ... DrugPatentWatch to its extensive list of ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) , ... pharmaceutical, drug patents and their expirations. ... business functions of patent agents and ...
Breaking Medicine Technology:Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Drug Patent Watch 2Drug Patent Watch 3
... July 1 Watson Pharmaceuticals, Inc. (NYSE: ... with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, ... Watson has commenced shipment of a generic version of ...  Exelon® is used to treat dementia (a brain disorder ...
... YORK , July 1 /PRNewswire-Asia-FirstCall/ -- NeoStem, ... an international,biopharmaceutical company with operations in the U.S. and ... Roberto Bolli , M.D., to its Scientific,Advisory Board. Dr. ... work emphasizing the ability of very small embryonic-like stem ...
Cached Medicine Technology:Watson Launches Generic Exelon® 2Watson Launches Generic Exelon® 3NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 2NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 3NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 4
(Date:6/20/2013)... Michigan-based natural health and wellness ... David R Hamilton which revealed that performing random acts ... in the release of the feel-good hormone Oxytocin in ... known as the ‘cardio protective’ hormone because it temporarily ... heart health. , “Being kind is something we can ...
(Date:6/20/2013)... Creighton University was named ... Roll – the highest federal recognition a college or ... service learning and civic engagement as well as meaningful ... for National and Community Service, is given to 690 ... foundation at Creighton is based on spiritual growth through ...
(Date:6/19/2013)... Paleo Burn has finally been released after much ... body they desire with no fad diets, pills, or extreme ... food products, Ken Smith was bold enough to expose the ... automatic, and permanent solution for weight loss. , ... a quick review of Paleo Burn, TotalWellnessCleanse.net believes this guide ...
(Date:6/19/2013)... Go Classy Tours has the reputation for ... over 25 Years. These resorts, draw many clients from ... bars and nude hot tubs. Grand Lido Negril was ... SuperClubs re-branded the resort to a Breezes and dis-continued the ... the Resort fell off dramatically. "Groups just went to ...
(Date:6/19/2013)... According to Fastcare , ... exposure is perhaps the biggest and certainly most ... is just one of many potential factors that ... Other risk factors include:, ,     Exposure ...     Heredity may play a role , ...
Breaking Medicine News(10 mins):Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3
... make citizens pay for others, abortions , Senate ... Bill doesn,t meet goals of affordability, fairness to legal ... Responding to reports of a new "compromise" proposal on abortion ... DiNardo today reaffirmed the position of the U.S. Conference of ...
... predestine anyone to abuse either, researchers say, , FRIDAY, Dec. ... to alcoholism also make them prone to becoming addicted to ... men and women aged 24 to 36, including almost 2,800 ... Registry, about their use of alcohol and marijuana over their ...
... ... consequences, won two prestigious honors: a place on The Washington Post’s Best Books of ... the coveted award. , ... Washington, DC (PRWEB) December 18, 2009 -- Steve Luxenberg’s Annie’s Ghosts: A Journey ...
... Dec. 18 Nationwide Health Properties, Inc. (NYSE: ... it is redeeming all of its outstanding shares of 7.75% ... (NHP-PB - CUSIP No. 638620302) on January 18, 2010 at ... equal to accumulated and unpaid dividends thereon to the redemption ...
... fruit rind fights drug-resistant infections, researchers say , ... can be turned into an ointment to treat ... dangerous methicillin-resistant Staphylococcus aureus (MRSA) bacteria, ... experiments, the team at Kingston University in London ...
... Dec. 18 Feeding America, the nation,s leading domestic hunger-relief ... more than $400,000 in adult and pediatric nutritionals originally intended ... 20 food banks in seven states and Puerto Rico. ... on a partnership to "pre-position" nutritional products to regions that ...
Cached Medicine News:Health News:'Abortion Compromise' Does Not Address Core Problem In Senate Health Bill, Says Cardinal DiNardo, Bishops' Pro-Life Chair 2Health News:'Abortion Compromise' Does Not Address Core Problem In Senate Health Bill, Says Cardinal DiNardo, Bishops' Pro-Life Chair 3Health News:Marijuana, Alcohol Addiction May Share Genes 2Health News:Marijuana, Alcohol Addiction May Share Genes 3Health News:Nonfiction Book on Family Secrets Wins Two Prestigious Honors 2Health News:Nonfiction Book on Family Secrets Wins Two Prestigious Honors 3Health News:Nonfiction Book on Family Secrets Wins Two Prestigious Honors 4Health News:Nationwide Health Properties, Inc. Announces the Redemption of All Outstanding Shares of 7.75% Series B Cumulative Convertible Preferred Stock 2Health News:More Medicinal Uses for Pomegranate 2Health News:Feeding America and Abbott Transform Disaster Preparedness Into Hunger Relief 2Health News:Feeding America and Abbott Transform Disaster Preparedness Into Hunger Relief 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: